King John C
Insider CIK 1738190 · RARX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 30,658 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 107,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 190,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer | 2020-04-02 | 2020-04-03 | 10,823 | $48.00 | $519.5K | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-04-16 | 2019-04-18 | 15,329 | — | $0 | 30,658 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | F Tax w/h | 2019-04-16 | 2019-04-18 | 4,506 | $21.93 | $98.8K | 10,823 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-04-16 | 2019-04-18 | 15,329 | — | $0 | 15,329 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 107,000 | — | $0 | 107,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-05-01 | 2018-05-02 | 45,987 | — | $0 | 45,987 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-05-01 | 2018-05-02 | 190,000 | — | $0 | 190,000 | SEC↗ |